TABLE 1.
Changes in the screening and detection trends for sexually transmitted infections in the clinical settings analyzed
| Samples for CT screening | CT-positive samples | LGV-positive samples | LGV/C. trachomatis | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2010/2017 a | 2019 | Increase | 2010/2017 a | 2019 | Increase | 2010/2017 a | 2019 | Increase | 2010/2017 a | 2019 | Increase | |
| STI1 | 5,276 | 14,011 | 2.7-fold | 437 | 1,434 | 3.3-fold | 30 | 225 | 7.5-fold | 6.8% | 15.7% | 2.3 |
| STI2 | 4,901 | 10,449 | 2.1-fold | 301 | 662 | 2.2-fold | 6 | 24 | 4.0-fold | 2.0% | 3.6% | 1.8 |
| Hospitals | 2,980 | 4,477 | 1.5-fold | 301 | 245 | −1.2-fold | 9 | 10 | −1.1-fold | 3% | 3.1% | 1.03 |
The period lasted 10 years, whereas in the other centers, the period lasted only 3 years (2017–2019).